Product Information
Download the PDF version of Prescribing Information (PDF, 54 Kb)
Download the PDF version of Patient Product Information (PDF, 197 Kb)
| You need to have Adobe® Acrobat® installed to view PDF files. If you do not have Acrobat® Reader®, you can download it for free from Adobe® website. |  |
 |
| Adobe® Reader® is a registered trademark of Adobe Systems, Inc. | ||
Neulasta® (pegfilgrastim) is prescribed to reduce the risk of infection (initially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.
Important safety information
Ruptured spleen (including fatal cases), a serious lung problem called acute respiratory distress syndrome, and serious allergic reactions have been reported. Call your doctor or seek emergency care right away if you have abdominal or shoulder tip pain, shortness of breath, trouble breathing, a fast rate of breathing, or any allergic reaction. The most common side effect of this injection is mild to moderate bone pain.
If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Important safety information
Ruptured spleen (including fatal cases), a serious lung problem called acute respiratory distress syndrome, and serious allergic reactions have been reported. Call your doctor or seek emergency care right away if you have abdominal or shoulder tip pain, shortness of breath, trouble breathing, a fast rate of breathing, or any allergic reaction. The most common side effect of this injection is mild to moderate bone pain.
If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2010 Amgen. All rights reserved.